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Synchrotron radiation circular dichroism (SRCD) is an emerging technique in 
structural biology with particular value in protein secondary structure analyses since it 
permits the collection of data down to much lower wavelengths than conventional 
circular dichroism (cCD) instruments. Reference database spectra collected on different 
SRCD instruments in the future as well as current reference datasets derived from cCD 
spectra must be compatible. Therefore there is a need for standardization of calibration 
methods to ensure quality control. In this study, magnitude and optical rotation 
measurements on four cCD and three SRCD instruments were compared at 192.5, 219, 
290 and 490 nm. At high wavelengths, all gave comparable results, however, at the lower 
wavelengths, some variations were observable. The consequences of these differences on 
the spectrum, and the calculated secondary secondary structure, of a representative 
protein (myoglobin) are demonstrated. A normalisation method is proposed for 
standardising spectra obtained on any CD instrument, conventional or SR-based, with 
respect to existing and future databases. 
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1.  Introduction: 
Synchrotron radiation circular dichroism (SRCD) spectroscopy is a method that 
was first developed more than 20 years ago [1,2] but which is just beginning to realise its 
full potential in the study of protein secondary structures. It permits the collection of 
much lower wavelength data than conventional circular dichroism (cCD) spectroscopy 
due to the high light flux available from the synchrotron source. Indeed, recently a 
protein spectrum in aqueous solution was obtained with a lower wavelength limit of <154 
nm [3], as compared to a practical limit of ~185-190 nm on conventional instruments.  It 
has been suggested that the extra information from the vacuum ultraviolet (VUV) data 
will allow a greater discernment of structural features, including information on folds and 
motifs [4]. Creation of a new reference database of protein CD spectra, including the 
lower wavelength data which will enable fold recognition studies, is in progress [3].  
There are currently a number of operational SRCD instruments world-wide [5], 
and several more will be coming on-line in the near future [6]. Therefore establishment of 
a consistent set of calibration standards and protocols for SRCD and cCD is now 
essential. Instrumental calibrations of magnitude, polarisation, and wavelength are 
needed, as are precise measurements of optical cell pathlengths and protein 
concentrations, in order to obtain the correct measurements of ellipticities that are 
necessary for secondary structural analyses [7-9]. Since the currently available reference 
databases for protein secondary structural analyses were derived from measurements 
made on cCD instruments [10], and future reference databases will be measured on 
SRCD instruments but must also be usable with cCD data, it is especially important that 
SRCD and cCD instruments are calibrated to the same standards [6]. Establishing 
protocols for calibration will also be important in the context of “good practice” 
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procedures for protein drug standardisation and characterisation in the pharmaceutical 
industry where CD is currently being employed to confirm batch to batch reproducibility 
of protein structure. 
Conventional circular dichroism instruments are routinely calibrated for 
amplitude at 290 nm using camphor sulphonic acid (CSA) [11] or ammonium 
camphorsulphonate (ACS) [12]. However, calibrations should be done at more than one 
wavelength [13] in order to cover the wavelength range measured in a protein spectrum, 
and to demonstrate the linearity of the response. Other candidates that have been 
proposed for calibration standards are the lower wavelength (192.5 nm) CSA peak [11], 
pantolactone (PL) [14] with a peak at 219 nm, and cobalt (III) tris-ethylenediamine (Co-
en), with a maximum at 490 nm [15], which also provides a good standard for the visible 
region.   
As a preliminary attempt at standardisation, this study compares optical rotation 
magnitude measurements for a number of compounds on three SRCD instruments with 
those obtained on four cCD instruments. In addition, spectra of the protein myoglobin 
were also measured on all these instruments in order to examine the effects of instrument 
variation on the spectrum of a standard protein. The calculated secondary structures 
derived from these spectra were then compared in order to determine the consequences of 
these variations. Finally, a method is proposed for standardisation of protein spectra 
obtained on any instrument which will “correct” the spectra and enable empirical 
analyses based on existing and future database spectra, using the values obtained for four 
standards on these instruments. 
 
2.  Materials and Methods: 
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Materials: 
(D)-(-)-pantolactone, of 99.99% purity (Sigma-Aldrich Company Ltd), was 
dissolved at a concentration of 0.0115 M in 18.2 MΩ distilled water (dH2O). (+)-
Camphor-10-sulphonic acid, 99% purity (Sigma-Aldrich Company Ltd), was dissolved in 
dH2O at a concentration of 0.047 M, determined by the absorbance at 285 nm initially 
assuming an extinction coefficient of 34.5 M−1 cm−1 [16]. The value of the extinction 
coefficient was verified during the course of this work as discussed below, and the 
original value found to be in error by only 1%. Co(ethylenediamine)3]Cl3.NaCl.6H2O, the 
kind gift of Peter W. Thulstrup (from Roskilde University, Denmark), was dissolved in 
dH2O at a concentration of 33.4 mM, as determined by the absorbance at 464 nm, using ε 
= 84 M−1cm−1 (McCaffery and Mason, 1967). The CSA sample was diluted to 
concentrations ranging from 0.9x to 0.1x  to assay the CD signal as a function of 
concentration, thereby enabling testing of the linearity of the response. The samples of 
CSA, PL and Co-en were stored in the dark at 4oC and used within 2 weeks of 
preparation. In the first set of experiments, the same samples (using the same CD cells) 
were tested on most of the machines (4 cCDs and 1 SRCD) within that 2 week period. 
These samples were retested on the first machine at the end of this time to ensure that no 
changes had taken place. Because of constraints associated with beamtime scheduling 
which did not permit measurements on the other two SRCDs to be done during the initial 
two week period, another sample was prepared in the same way and was used for 
measurements on them, and for comparison, on one of the cCDs that had been used for 
the first set of measurements.  
Horse skeletal myoglobin (ICN Biochemicals) was allowed to dissolve in dH2O 
overnight at a concentration of ~8 mg/ml. One ml of the solution was then dialysed 
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against 50 ml of dH2O for 2 hrs to reduce the salt content, and centrifuged at 5000 × g to 
separate any undissolved material. The final concentration of the protein was determined 
to be 7.43 mg/ml by replicate quantitative amino acid analyses. 
CD and SRCD spectroscopy: 
The following parameters were set on all instruments: bandwidth 1 nm, step size 
0.2 nm, temperature 25oC. Spectra were collected on the Aviv 62ds and 215 instruments 
and on all the SRCD instruments in step scan mode with an averaging (dwell) time of 1 
second. At least 3 measurements were made and averaged for each sample on each 
instrument. The Jasco J-600 and J-715 instruments were run in continuous scan mode, 
averaging over 8 accumulations with a response time of 0.5 s. The PL, CSA, and Co-en 
spectra were all collected using a 1 mm pathlength Suprasil cell (Hellma UK Ltd). A 
dH2O baseline, collected using the same cuvette and the same parameters, was subtracted 
from all spectra. All myoglobin spectra were obtained using the same cylindrical 0.001 
cm pathlength demountable cell from Hellma UK Ltd held in a specially adapted cell 
holder; dH2O baselines were collected in the same cell. 
SRCD measurements were made at the SRS Daresbury (UK) on beamline CD12; 
at ISA (Denmark) on beamline UV1; and at BESSY2 (Germany) on beamline 
3m_NIM1_C. Where possible, the parameters were set to the values used on the cCD 
instruments. On 3m_NIM1_C there was no bandwidth control, so the slits were fully 
open, and due to limited beamtime, only 2 repeats were done. Because two of the  
beamlines had upper wavelength limits of <400 nm, measurements on the Co-en sample 
were not possible. The SRCD instrument on beamline CD12 records intensities as 
arbitrary counts. Therefore, the literature value for CSA at 290 nm was assumed and the 
other values calculated from this for the CD12 data. 
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The pathlengths of the optical cells used were determined using the absorbance of 
a 1 mM solution of potassium chromate (ε372 = 4830 M-1cm-1 (Chemical Rubber 
Company)) and by the interference fringe method (Hennessey and Johnson, 1982) for the 
(nominally) 0.1 and 0.001 cm cells, respectively.  
Secondary Structure Calculations: 
The secondary structural analyses used the DICHROWEB 
(http://www.cryst.bbk.ac.uk/cdweb) interactive webserver [8] with the CONTIN [10,18] 
algorithm and database 6 [8]. The normalised root mean square deviation (NRMSD) 
parameter [19] was calculated as a means of assessing the goodness-of-fit.  
Standardisation Method: 
 For each of the instruments for which measurements were available for all four 
standards, a standardisation procedure was applied to the myoglobin spectrum collected 
on that instrument. This was done as follows: for each standard, the literature delta 
epsilon value was divided by the delta epsilon value measured on that instrument. Then a 
second-order polynomial was fit to the ratios at the four different wavelengths, and the 
ratio values at all other wavelengths (Rλ) were interpolated from the ratio versus 
wavelength curve. Then for the myoglobin data at each point, the scaled delta epsilon 
value (Δεsλ) = (Rλ) * (Δελ) was plotted as the “standardised” spectrum.  The proposed 
procedures are detailed in Annex 1 of this paper. 
  
3.  Results: 
One advantage of this study is that the comparative measurements could be done 
on equivalent samples (close in time and prior to degradation) using the same CD cell 
(and thus the same pathlength), by the same investigator, thereby eliminating many 
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possible sources of systematic errors, and enabling a true comparison of the instrument 
characteristics.   
a.   Accuracy of Optical Rotation Magnitude Measurements:  
Pantolactone has a Δε at 219 nm of –4.9 mdeg M-1cm-1 [20] therefore a signal of 
186 mdeg was expected at this wavelength for the 0.0115 M solution used in this work.  
CSA has a Δε at 290 nm is 2.37 mol−1 dm3 cm−1 [20] therefore a signal of 367 mdeg was 
expected for the 0.047 M solution used in this work. Δε for the second CSA peak at 192.5 
nm is 4.72 mol−1 dm3 cm−1 [11]. Therefore a peak of 146 mdeg was expected from a 5 
times dilution of the CSA sample.  It should be noted that the CSA (and all peaks) varied 
in wavelength between the different instruments: The low wavelength CAS peak was 
found at positions ranging fro9m 190.5 and 194.0 nm (average 191.7 nm), and the high 
wavelength peak was between 189.1 and 193.2 nm (average 290.4 nm).  Thus calibration 
of wavelength position is another important parameter to consider for instrument 
standardisation (Miles & Wallace, in prep). In this paper, the ellipticity values reported 
are always for the peak maximum, regardless of what the wavelength position was. 
Assuming enantiomeric purity, with a Δε at 490 nm of 1.89 mdeg M−1cm−1 
(McCaffery and Mason, 1963), Co-en should give rise to a CD signal of 208 mdeg. The 
results obtained on all instruments are displayed graphically in Figure 1a. The “literature 
value” curve is established by a simple fit (Excel) to the four data points and is for 
visualisation purposes only. For clarity, all the cCD measurements are shown as open 
symbols, and all the SRCD measurements are shown as filled symbols. A given symbol 
signifies data measured on a single instrument. 
Since instruments are generally routinely calibrated using the CSA 290 nm peak, 
it is not surprising that they all correspond well to each other and to the literature value at 
 8 
this wavelength. However, the deviations are considerably larger at lower wavelengths 
(i.e. as high as 18% at 192.5 nm for one SRCD instrument). 
At 490 nm, all ellipticity measurements were within 6% of the literature value. 
Variations for single machines across all four wavelength standards range from 0 to 3% 
for one cCD instrument, to 4 to 18% for another cCD instrument, with the SRCD 
instruments falling in the middle (0 to 10%). The variations include both too large and 
too small values, with no particular pattern being discernable. Also, there is no clear trend 
of deviation between cCDs or the SRCDs. The most significant result is that none of the 
instruments vary by a constant amount from the literature values across all wavelengths, 
so no simple scale factor can be applied. This is in complete contrast to the common 
practice whereby one calibrates an instrument at a single point and assumes this means 
the whole wavelength range is in calibration. 
At all three UV wavelengths, two of the cCDs are calibrated to within 3% of the 
expected value. This is close to the 2% error level estimated from the repeated 
measurements. One cCD displays significant deviation at 219 nm (−10%) and another 
deviates by +11% at 192.5 nm and +18% at 219 nm. One SRCD instrument was found to 
have a deviation of ~8% at all the wavelengths measured, whilst another was within 4 % 
of the literature values at three wavelengths, but deviates at 192.5 nm by >10%, hence its 
192.5/290 peak ratio is the highest value measured, 2.20.  
b.  Linearity of Detector Response: 
It is important to demonstrate that the instruments produce linear responses across 
the range of ellipticity values measured, in order for the CSA dilution calculations to be 
correct. This was assayed by measuring a series of dilutions of the CSA sample, and 
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plotting ellipticity versus concentration (data not shown). All instruments surveyed 
exhibited linear responses up to ellipticity values of 300 mdeg.   
Another important issue to consider is the total absorbance, often measured as 
high tension (HT) of the sample. When the sample absorbance is too high, the number of 
photons reaching the detector becomes too small for accurate measurement and the CD 
signals cannot be trusted. The cut-off in instrument performance must therefore 
determined on each individual instrument.  In this study, all measurements were done 
under conditions where the absorbance was still within the measurable range. 
c.  CD Signal Ratios:  
The ratio of the ellipticities of the two CSA peaks (Δε192.5 nm/Δε290nm) is often used 
as a simple “two-point” means of calibrating the instrument, as opposed to the absolute 
measurement of the ellipticity of a single peak. Reported values in the literature range 
from ~1.90 to >2.10 (ie., [11, 17, 21, 22]). In this study, the values for the ratio ranged 
from 1.96 to 2.20 (Figure 1b). However, this parameter on its own is not particularly 
useful, as the absolute magnitude may be incorrect, whilst the ratio is reasonable. Also, 
there is no clear standard for the “correct” value, with significant variations possible due 
to, amongst other sources, CSA purity, light-induced degradation, and instrument stray 
light. Hence, we consider the magnitude of the individual peaks may be a more suitable 
measure of the CD. However, they are dependent on having accurate values for the 
extinction coefficients and ellipticity values for the standard materials. 
d.  Effects of Instrumental Variation on Protein Spectra:  
 The variations between instruments for the standards are considerable in the 
critical far UV spectral range used for protein analyses. The obvious consequences of this 
is that protein spectra measured on the various instruments will differ considerably both 
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in magnitude and shape (the latter because the deviations from true signals are different 
for different wavelengths) from each other (Figure 1c) and from the myoglobin spectrum 
in the reference database (black curve- Figure 1c). Therefore the simple scaling of all the 
spectra by a factor determined at one wavelength will not produce equivalent spectra. To 
illustrate this, all the spectra were normalised to the literature values at each of the single 
UV wavelengths (192.5, 219 and 290 nm), and replotted (Figures 1d-f). The most 
successful of these was the scaling to the 219 peak, but in this case the spectra showed 
some variation, especially the one outlier (green) that had very different values for the 
standards at all wavelengths. Nevertheless, none of the single wavelength scalings 
produced very good correspondences. An alternative, the four-point normalisation 
method, described above, resulted in very close correspondences with each other and 
with the spectrum in the reference database (Figure 1f). 
e.   Effects of Instrumental Variation on Calculated Secondary Structures:  
Two instruments (one cCD and one SRCD) produce spectra nearly identical to the 
reference data base spectrum of myoglobin, so it is no surprise that they produce similar 
calculated secondary structures. However, the unscaled spectra (Figure 1c) produce 
dramatically different calculated secondary structures (ranging from 0.44−0.83, average 
0.71), where the value calculated by the DSSP algorithm from the crystal structure [23] 
was 0.75. This results demonstrates that without proper cross-calibration, empirical 
methods for secondary structural analyses will not work for either cCD or SRCD 
measurements.  However, after the four-point normalisation scaling, the resulting spectra 
produced a narrower range of secondary structures (average = 0.72, range 0.70−0.74).  
On this basis, we propose that the scaling method described may be a useful one for both 
cCD and SRCD data. 
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4.  Discussion: 
 
a.  Comparisons of cCD and SRCD Spectra:  
It can be seen that there is considerable variation between spectra obtained on 
various instruments, with no clear segregation into cCD and SRCD populations, and no 
clear trend between or within the types of instruments. There is very close 
correspondence between one of the cCD instruments (red) and one of the SRCD 
instruments (light blue). In a previous study, it was suggested that at the very low 
wavelength limits conventional spectra differ slightly from SRCD spectra [24]; this was 
attributed to the necessity of fully opening the slits in the cCD to achieve high enough 
light flux, which ultimately allowed through light of other wavelengths. The purpose of 
the present study, however, was to examine the correlations at wavelengths where both 
instruments are operating optimally, i.e. above ~190 nm.   
b.  Proposed Standardisation Method for Calibration Corrections: 
The variations between the measurements of the standards on the various 
instruments are reflected in the spectra of the protein sample. The overall magnitudes and 
the relative peak magnitudes are significantly different in spectra from the different 
instruments (Figure 1c), and most experimental spectra are at variance with the 
corresponding spectrum from the reference database (in black, Figure 1c). These spectral 
differences result in large differences and inaccuracies in the calculated secondary 
structures derived from them. The variations could also lead to problems in use of CD for 
“good practice” quality control analyses of pharmaceutical proteins if uncorrected data 
from different instruments were compared. As a result, it is clear that there needs to be 
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some procedure that can be used to standardise/calibrate the spectra taken on one 
instrument with the spectra taken on other instruments and in the reference databases. 
The established method for calibration of cCD instruments uses only the value for 
the CSA calibration at 290 nm to normalise the spectra on a given instrument. That this is 
actually not a very suitable method (see Figure 1f) is unsurprising given that this peak is 
outside the far UV wavelength range of used for measuring protein spectra. 
Normalisations using either the 192.5 nm CSA or the 219 nm PL peaks are somewhat 
better (Figures 1d and 1e) but still do not take into account the wavelength-dependent 
variations. Hence we propose a new procedure which utilises the ratios of the measured 
and expected delta epsilon values at each wavelength to develop a model function for 
corrections to be applied to spectra. This has proved to be a much more successful 
method of calibration that any single wavelength approach, resulting in superposable 
spectra from the various instruments and with the corresponding spectrum from the 
reference dataset (Figure 1g).  
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Figure Legends: 
 
1.  Variations between different instruments: (a) Amplitude variations of four cCD and 
three SRCD instruments for three standard compounds (CSA, PL, and Co-en) at four 
wavelengths. The “literature value” curve is established by a simple fit to the values, and 
is for visualisation purposes only. cCD measurements are shown as open symbols, SRCD 
measurements are shown as filled symbols. A given symbol signifies data measured on a 
single instrument. (b)  Plot of (Δε192.5 nm/Δε290nm) ratios of CSA for the cCD and SRCD 
instruments, using the same symbols as in Figure 1a. (c) Uncorrected myoglobin spectra 
obtained on cCD and SRCD instruments. All spectra were obtained using the same 
concentration of protein and the same cell (and hence the same pathlength). The spectra 
from the cCD instruments are shown in red/orange/yellow/purple; the spectra from the 
SRCD instruments are in light and dark blue and green (in each case, the same colour as 
used for the symbols in Figure 1a). The spectrum of myoglobin from the reference 
database [10] is shown in black, for comparison. (d-f) Myoglobin spectra from various 
instruments scaled to calibration points at (c) 290 nm, (d) 219 nm, and (e) 192.5 nm, 
respectively. It can be seen that there is still considerable variation between spectra 
obtained on different instruments, with no clear segregation into cCD and SRCD 
populations. (g) Convergence of the myoglobin spectra after standardisation by the 
multiwavelength (“four-point”) method proposed in this paper. 
2.  Examples of application of standardisation method to data collected on two different 
CD instruments (blue and orange curves): (a)  Uncorrected spectra of myoglobin obtained 
on the two CD instruments. (b)   Plots of Rλ vs. wavelength for the two instruments, 
dervived from the four standard measurements. (c)  Corrected (according to the method 
described in Annex 1) spectra of myoglobin obtained on the two CD instruments. 
 15 
 
a                c 
    
d      e 
    
f      g 
Figure 1 
 
 
 
b 
 
 16 
 
a 
 
b 
 
c 
 
 
Figure 2
 17 
References: 
[1]  J.C. Sutherland, E.J. Desmond and P.Z. Takacs. Versatile spectrometer for 
experiments using synchrotron radiation at wavelengths greater than 100 nm. Nucl. Instr. 
Meth. 172 (1980),195-199. 
[2]  P.A. Snyder and E.M.Rowe. The first use of synchrotron radiation for vacuum 
ultraviolet circular dichroism measurements. Nucl. Instr. Meth. 172 (1980), 345-349. 
[3]  B.A. Wallace, F. Wien, A.J. Miles, J.G. Lees, P. Evans, S.V. Hoffman, G.J. Wistow 
and C. Slingsby. Biomedical applications of synchrotron radiation circular dichroism 
spectroscopy: Identification of mutant proteins associated with disease and development 
of a reference database for fold motifs, J. Chem. Soc. (2003), in press. 
[4]  B.A. Wallace and R.W. Janes. Synchrotron radiation circular dichroism spectroscopy 
of proteins:  Secondary structure, fold recognition, and structural genomics.  Curr. Opin. 
Chem. Biol. 5 (2001), 567-571.  
[5]  B.A. Wallace. Synchrotron radiation circular dichroism spectroscopy as a tool for 
investigating protein structures. J. Synch. Rad. 7 (2000), 289-295. 
[6]  B. A. Wallace.  First International Workshop on SRCD Spectroscopy. Synchrotron 
Radiation News 15 (2002), 20-22. 
[7]  Wallace, B.A. and Teeters, C.L. Differential absorption flattening optical effects are 
significant in the circular dichroism spectra of large membrane fragments.  Biochemistry 
26 (1987), 65-70. 
[8]  A. Lobley, L. Whitmore and B.A. Wallace. DICHROWEB: an interactive website for 
the analysis of protein secondary structure from circular dichroism spectra. 
Bioinformatics 18 (2002), 211-212.  
[9]  L. Whitmore, A. Miles, and B.A. Wallace, in preparation. 
 18 
[10]  N. Sreerama, and R.W. Woody. Estimation of protein secondary structure from CD 
spectra: Comparison of CONTIN, SELCON and CDSSTR methods with an expanded 
reference set.  Anal. Biochemistry 282 (2000), 252-260. 
[11]  G.C. Chen and J.T. Yang, Two-point calibration of circular dichrometer with d-10-
camphorsulfonic acid. Anal. Lett. 10 (1977), 1195-1207. 
[12]  T. Takakuwa, T. Konno and H. Meguro. A new standard substance for calibration 
of circular dichroism: ammonium d-10-camphorsulfonate. Anal. Sci. 1 (1985), 215-218. 
[13]  K. Tuzimura, T. Konno, H. Meguro, M. Hatano, T. Murakimi, K. Kashiwabara, K. 
Saito, Y. Kondo and T.M. Suzuki. A critical study of the measurement and calibration of 
circular dichroism. Anal. Biochem. 81 (1977), 167-174.  
[14]  T. Konno, H. Meguro and K Tuzimura.  D-Pantolactone as a circular dichroism 
(CD) calibration. Anal. Biochem. 67 (1975), 226-232. 
[15]  A.J. McCaffery and S.F. Mason. The electronic spectra, optical rotatory power and 
absolute configuration of metal complexes: The dextro-tris (ethylenediamine)colbalt (III) 
ion. Mol. Phys. 6 (1963), 359-371. 
[16] T.M. Lowry, Optical Rotatory Power, Dover Publications, New York (1964), p 407. 
[17]  J.P. Hennessey, Jr and W. C. Johnson, Jr. Experimental errors and their effect on 
analysing circular dichroism spectra of proteins. Anal. Biochem.125 (1982), 177-188. 
 [18] I.H.M. Van Stokkum, H.J.W. Spoelder, M. Bloemendal, R.Van Grondelle and 
F.C.A. Groen. Estimation of protein secondary structure and error analysis from CD 
spectra. Anal. Biochemistry 191 (1990), 110-118. 
[19] D. Mao, E. Wachter, and B.A.Wallace. Folding of the H+-ATPase  proteolipid in 
phospholipid vesicles. Biochemistry 21(1982), 4960-4968. 
 19 
[20]  P.H. Schippers and H.P.J.M. Dekkers. Direct determination of absolute circular 
dichroism data and calibration of commercial instruments. Anal. Chem. 53 (1981), 778-
782. 
[21]  W.C. Johnson, Jr. Circular Dichroism Instrumentation. in: Circular Dichroism and 
the Conformational Analysis of Biomolecules,1996, Plenum Press, New York, p635-652. 
[22]  S.Y. Venyaminov and J.T. Yang.  Determination of Protein Secondary Structure.  
in: Circular Dichroism and the Conformational Analysis of Biomolecules,1996, Plenum 
Press, New York, p69-107. 
[23]  B.A. Wallace, J. Lees, A.J.W. Orry, A. Lobley and R.W. Janes, R.W. Analyses of 
Circular Dichroism Spectra of Membrane Proteins. Protein Science 12 (2003), 875-884. 
[24] J. Lees and B.A. Wallace, Synchrotron radiation circular dichroism and conventional 
circular dichroism spectroscopy: A comparison. Spectroscopy 16 (2002), 121-125. 
 20 
Annex 1:  Protocol for Four-Point Standardisation Method 
1.  Measure the CD spectrum of the protein of interest (Figure 2a). 
2.  Measure the CD spectra for the three standards (CSA, PL, Co-en) at the following four 
wavelengths: 192.5, 219, 290, 490 nm. 
3.  For the above standard measurements, calculate the ratio (Rλ) of the literature value 
for the delta epsilon divided by the measured value for the delta epsilon. 
4.  Fit a second order polynomial to the four Rλ vs. wavelength data points (Figure 2b). 
4.  Determine the value of the polynomial (Rλ)for each wavelength over the whole 
spectral range. 
6.  Multiply the CD spectrum of the protein of interest by the Rλ value at each 
wavelength and plot the resulting standardised spectrum (Figure 2c). 
